⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Table S1, S2 from DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer

Abigail L. Miller Naiara Perurena Alycia Gardner Toshinori Hinoue Patrick Loi Peter W. Laird Karen Cichowski

View at Publisher

Ask AI

Bookmark

Share

Abstract

Table S1: Genes enriched in tumor macrophages, Table S2: The methylation of RASGAPs in human colorectal cancer (TCGA)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Miller et al. (2024) studied this question.

synapsesocial.com/papers/68e586c1b6db64358752359a https://doi.org/10.1158/0008-5472.27027473

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S1, S2 from DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer2024
2Data from DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer2024
3Figure S1 from DAB2IP is a bifunctional tumor suppressor that regulates wildtype RAS and inflammatory cascades in KRAS mutant colon cancer2024
4Table S3 from Dual inhibition of KRASG12D and pan-ERBB is synergistic in pancreatic ductal adenocarcinoma2024
5Table S3 from Dual inhibition of KRASG12D and pan-ERBB is synergistic in pancreatic ductal adenocarcinoma2024

More related papers

Divergent transcriptomic signatures and microenvironmental markers of <i>KRAS</i> and <i>BRAF</i> mutations in colorectal cancer: A multi-omics integrative analysis.2026
Table S1 from Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer2024
Table S1 from Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer2024